- Home
- JWEL vs TTNP Comparison
JWEL vs TTNP Comparison
Compare JWEL & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- TTNP
- Stock Information
- Founded
- JWEL 2012
- TTNP 1991
- Country
- JWEL China
- TTNP United States
- Employees
- JWEL N/A
- TTNP N/A
- Industry
- JWEL Other Consumer Services
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JWEL Consumer Discretionary
- TTNP Health Care
- Exchange
- JWEL Nasdaq
- TTNP Nasdaq
- Market Cap
- JWEL 4.1M
- TTNP 3.3M
- IPO Year
- JWEL 2021
- TTNP 1996
- Fundamental
- Price
- JWEL $2.43
- TTNP $3.50
- Analyst Decision
- JWEL
- TTNP
- Analyst Count
- JWEL 0
- TTNP 0
- Target Price
- JWEL N/A
- TTNP N/A
- AVG Volume (30 Days)
- JWEL 881.8K
- TTNP 28.0K
- Earning Date
- JWEL 12-27-2024
- TTNP 12-27-2024
- Dividend Yield
- JWEL N/A
- TTNP N/A
- EPS Growth
- JWEL N/A
- TTNP N/A
- EPS
- JWEL N/A
- TTNP N/A
- Revenue
- JWEL $160,009,293.00
- TTNP $3,000.00
- Revenue This Year
- JWEL N/A
- TTNP N/A
- Revenue Next Year
- JWEL N/A
- TTNP N/A
- P/E Ratio
- JWEL N/A
- TTNP N/A
- Revenue Growth
- JWEL N/A
- TTNP N/A
- 52 Week Low
- JWEL $1.00
- TTNP $3.24
- 52 Week High
- JWEL $3.71
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- JWEL 45.33
- TTNP 40.70
- Support Level
- JWEL $2.45
- TTNP $3.24
- Resistance Level
- JWEL $3.13
- TTNP $3.93
- Average True Range (ATR)
- JWEL 0.38
- TTNP 0.40
- MACD
- JWEL -0.09
- TTNP -0.01
- Stochastic Oscillator
- JWEL 4.03
- TTNP 20.63
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.